Matches in Nanopublications for { <https://w3id.org/ro-id/d8e686b6-199a-4296-88fa-3c03cdb5a4c1/> ?p ?o ?g. }
Showing items 1 to 21 of
21
with 100 items per page.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 type BibliographyResearchObject assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 type BibliographyResearchObject assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 type ResearchObject assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 type LiveRO assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 type Dataset assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 description "The ongoing COVID-19 pandemic still requires fast and effective efforts from all fronts, including epidemiology, clinical practice, molecular medicine, and pharmacology. A comprehensive molecular framework of the disease is needed to better understand its pathological mechanisms, and to design successful treatments able to slow down and stop the impressive pace of the outbreak and harsh clinical symptomatology, possibly via the use of readily available, off-the-shelf drugs. This work engages in providing a wider picture of the human molecular landscape of the SARS-CoV-2 infection via a network medicine approach as the ground for a drug repurposing strategy. Grounding on prior knowledge such as experimentally validated host proteins known to be viral interactors, tissue-specific gene expression data, and using network analysis techniques such as network propagation and connectivity significance, the host molecular reaction network to the viral invasion is explored and exploited to infer and prioritize candidate target genes, and finally to propose drugs to be repurposed for the treatment of COVID-19. Ranks of potential target genes have been obtained for coherent groups of tissues/organs, potential and distinct sites of interaction between the virus and the organism. The normalization and the aggregation of the different scores allowed to define a preliminary, restricted list of genes candidates as pharmacological targets for drug repurposing, with the aim of contrasting different phases of the virus infection and viral replication cycle." assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 contentSize "5737" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 dateCreated "2021-12-10 09:57:03.314406+00:00" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 creation_mode "MANUAL" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 cite-as "Foglini, Federica. "Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19." ROHub. Dec 10 ,2021. https://w3id.org/ro-id/d8e686b6-199a-4296-88fa-3c03cdb5a4c1." assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 about 5881 assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 name "Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 contentUrl "https://api.rohub.org/api/ros/d8e686b6-199a-4296-88fa-3c03cdb5a4c1/crate/download/" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 creator mailto:service-account-generation-service assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 dateModified "2025-03-05 00:50:11.962750+00:00" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 datePublished "2021-12-10 09:57:03.314406+00:00" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 encodingFormat "application/ld+json" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 hasPart 424605bc-3aaa-4d60-b516-8c57721e8c90 assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 identifier "https://w3id.org/ro-id/d8e686b6-199a-4296-88fa-3c03cdb5a4c1" assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 license no-permission assertion.
- d8e686b6-199a-4296-88fa-3c03cdb5a4c1 author 0000-0002-2736-0052 assertion.